Investments
39Portfolio Exits
9Funds
4About CDIB Capital International
CDIB Capital International is an Asian private equity investor focused on middle-market growth capital transactions, with a sectoral bias for consumer/retail, media/technology, value-added manufacturing, and financial/business services. It is an affiliate of China Development Financial, one of the oldest and largest merchant banking groups in Greater China with over US$17bn in assets.
CDIB Capital International Headquarters Location
Suites 701-4, ICBC Tower, Citibank Plaza 3 Garden Road Central
Hong Kong
+852 2231 8600
Latest CDIB Capital International News
Jan 25, 2022
Tunisian artificial intelligence start-up InstaDeep announced that it raised $100 million and closed a successful Series B funding round led by Alpha Intelligence Capital and CDIB Capital International. The firm is focused on decision-making AI systems and will use this capital injection to hire more elite talent and expand its global prescence into the US. InstaDeep plans to accelerate the launch of disruptive AI products across multiple industries including biotech, logistics, transportation and electronics manufacturing. BioNTech, Chimera Abu Dhabi, DB Digital Ventures, Google, G42 and Synergie also participated in the funding round that will allow the company to harness AI technologies such as Reinforcement Learning, a type of machine learning that helps design effective optimization strategies for an array of challenges, from therapeutics development to railway operations and more. What started as an enthusiastic project to boost local AI communities in 2014 quickly grew from the two laptops of the founders into an influential organisation with a legion engineers and researchers in Tunisia, South Africa, Nigeria, the UAE and teams in France and the UK. “This funding round is a tremendous vote of confidence from our partners BioNTech, Google and Deutsche Bahn after working closely with us on innovative, high-impact AI initiatives” said Karim Beguir, Co-Founder and CEO of InstaDeep. “And we are very excited to get the support of Alpha Intelligence Capital, Chimera, Synergie and G42 as we see wide-ranging opportunities to deploy our AI products to tackle complex real-world problems.” InstaDeep and BioNTech have been strategic collaborators since the pairing launched a joint AI innovation lab in 2020 to deploy AI and machine learning techniques in immunotherapy development. One product this partnership created is an early warning system that detects high-risk SARS-CoV-2 variants. The AI-driven system detected Omicron and other WHO designated variants The AI-driven system detected Omicron when the sequence was made available and had already detected almost all of the WHO designated variants of concern about two months ahead of time. Google and Deutsche Bahn (DB Digital Ventures) are also collaborators through respective joint research publishing with DeepMind and Google Research, and a project that will automate railway scheduling. “As the first global fund fully dedicated to artificial intelligence and machine learning, we are particularly proud to have led this Series B round, together with first class co-investors,” says Alpha Intelligence Capital partner and COO Arnaud Barthelemy. “InstaDeep is a deep technology company that disrupts traditional approaches in crucial areas as they do with BioNTech for drug discovery or with Deutsche Bahn for railway scheduling. We are thrilled to join this exciting adventure and eager to help support InstaDeep’s growth through our unique AI expertise.” The company was supported by law firm CMS during this fundraising round.
CDIB Capital International Investments
39 Investments
CDIB Capital International has made 39 investments. Their latest investment was in AsiaYo as part of their Series C on July 7, 2022.
CDIB Capital International Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
7/7/2022 | Series C | AsiaYo | $12.5M | No | 4 | |
6/16/2022 | Series D | Aidoc Medical | $110M | Yes | 2 | |
2/16/2022 | Series A | AmazingTalker | $15.5M | Yes | 4 | |
1/25/2022 | Series B | |||||
10/28/2021 | Series A |
Date | 7/7/2022 | 6/16/2022 | 2/16/2022 | 1/25/2022 | 10/28/2021 |
---|---|---|---|---|---|
Round | Series C | Series D | Series A | Series B | Series A |
Company | AsiaYo | Aidoc Medical | AmazingTalker | ||
Amount | $12.5M | $110M | $15.5M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 4 | 2 | 4 |
CDIB Capital International Portfolio Exits
9 Portfolio Exits
CDIB Capital International has 9 portfolio exits. Their latest portfolio exit was ACT Genomics on November 22, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
11/22/2021 | Merger | 2 | |||
Date | 11/22/2021 | ||||
---|---|---|---|---|---|
Exit | Merger | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
CDIB Capital International Acquisitions
1 Acquisition
CDIB Capital International acquired 1 company. Their latest acquisition was Coffee Bean & Tea Leaf on September 12, 2013.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/12/2013 | Acq - Fin | 1 |
Date | 9/12/2013 |
---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acq - Fin |
Sources | 1 |
CDIB Capital International Fund History
4 Fund Histories
CDIB Capital International has 4 funds, including Global Opportunities Fund.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/26/2018 | Global Opportunities Fund | Diversified Private Equity | Open | $116M | 1 |
8/3/2015 | CDIB Capital Asia Partners Fund | ||||
5/20/2015 | CDIB Capital Funds Partners LP | ||||
CDIB Capital Cross Border Fund |
Closing Date | 9/26/2018 | 8/3/2015 | 5/20/2015 | |
---|---|---|---|---|
Fund | Global Opportunities Fund | CDIB Capital Asia Partners Fund | CDIB Capital Funds Partners LP | CDIB Capital Cross Border Fund |
Fund Type | Diversified Private Equity | |||
Status | Open | |||
Amount | $116M | |||
Sources | 1 |
CDIB Capital International Team
9 Team Members
CDIB Capital International has 9 team members, including current President, Lionel de Saint-Exupery.
Name | Work History | Title | Status |
---|---|---|---|
Lionel de Saint-Exupery | President | Current | |
Justin Busarakamwong | Senior Vice President | Current | |
Neville Chan | Senior Vice President | Current | |
Stephen Choi | TVG | Senior Vice President | Current |
Steven Wu | CVM, and WI Harper Group | Senior Vice President | Current |
Name | Lionel de Saint-Exupery | Justin Busarakamwong | Neville Chan | Stephen Choi | Steven Wu |
---|---|---|---|---|---|
Work History | TVG | CVM, and WI Harper Group | |||
Title | President | Senior Vice President | Senior Vice President | Senior Vice President | Senior Vice President |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.